IFNB1 and neoplasm: Within the tumor, CV8102 alone, and in combination with systemic anti-PD-1 treatment, induced similar amounts of IFN-α, IFN-β, IL-6, and TNF, while anti-PD-1 antibodies alone did not induce these cytokines (Fig. 6a).